These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8543519

  • 1. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
    Pelham WE, Swanson JM, Furman MB, Schwindt H.
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
    [Abstract] [Full Text] [Related]

  • 2. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J, Wigal SB, Spencer TJ, McGough JJ, Mays DA.
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE, Greenslade KE, Vodde-Hamilton M, Murphy DA, Greenstein JJ, Gnagy EM, Guthrie KJ, Hoover MD, Dahl RE.
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [Abstract] [Full Text] [Related]

  • 4. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
    Riggs PD, Thompson LL, Mikulich SK, Whitmore EA, Crowley TJ.
    J Am Acad Child Adolesc Psychiatry; 1996 Aug; 35(8):1018-24. PubMed ID: 8755798
    [Abstract] [Full Text] [Related]

  • 5. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 6. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting.
    Swanson J, Wigal S, Greenhill L, Browne R, Waslick B, Lerner M, Williams L, Flynn D, Agler D, Crowley KL, Fineberg E, Regino R, Baren M, Cantwell D.
    Psychopharmacol Bull; 1998 Nov; 34(1):55-60. PubMed ID: 9564199
    [Abstract] [Full Text] [Related]

  • 7. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.
    McCracken JT, Biederman J, Greenhill LL, Swanson JM, McGough JJ, Spencer TJ, Posner K, Wigal S, Pataki C, Zhang Y, Tulloch S.
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):673-83. PubMed ID: 12921475
    [Abstract] [Full Text] [Related]

  • 8. Pemoline in ADHD.
    Winsberg B, Barbato M.
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
    [No Abstract] [Full Text] [Related]

  • 9. Open-label use of placebos in the treatment of ADHD: a pilot study.
    Sandler AD, Bodfish JW.
    Child Care Health Dev; 2008 Jan; 34(1):104-10. PubMed ID: 18171451
    [Abstract] [Full Text] [Related]

  • 10. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.
    Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A.
    J Clin Psychopharmacol; 1999 Jun; 19(3):257-64. PubMed ID: 10350032
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E.
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [Abstract] [Full Text] [Related]

  • 12. Methylphenidate dosing: twice daily versus three times daily.
    Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ.
    Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 14. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
    Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M.
    J Child Adolesc Psychopharmacol; 2000 Feb; 10(3):205-16. PubMed ID: 11052410
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ, Swanson JM, Coghill D, DeCory HH, Hatch SJ.
    BMC Psychiatry; 2004 Sep 30; 4():28. PubMed ID: 15458569
    [Abstract] [Full Text] [Related]

  • 17. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models.
    Denney CB, Rapport MD.
    J Am Acad Child Adolesc Psychiatry; 1999 Apr 30; 38(4):393-401. PubMed ID: 10199110
    [Abstract] [Full Text] [Related]

  • 18. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse.
    Heiligenstein E, Anders J.
    J Am Coll Health; 1997 Mar 30; 45(5):225-9. PubMed ID: 9069682
    [Abstract] [Full Text] [Related]

  • 19. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan 30; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.
    James RS, Sharp WS, Bastain TM, Lee PP, Walter JM, Czarnolewski M, Castellanos FX.
    J Am Acad Child Adolesc Psychiatry; 2001 Nov 30; 40(11):1268-76. PubMed ID: 11699800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.